ClinConnect ClinConnect Logo
Search / Trial NCT06903104

Acceptability and Feasibility of a Stress Prevention Program Based on Meditation and Acceptance and Commitment Therapy for Staff at a Cancer Center

Launched by INSTITUT DE CANCÉROLOGIE DE LORRAINE · Mar 24, 2025

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

Ma Eva Program Quality Of Life Mindfulness Workplace Caregivers

ClinConnect Summary

This clinical trial is looking at a program called MAEva, which uses meditation and Acceptance and Commitment Therapy to help reduce stress for employees working at a Cancer Center. The program consists of three sessions held once a week, where participants will learn different meditative practices and discuss important themes related to mindfulness and values. Before and after the program, participants will fill out surveys to measure their quality of life and stress levels, allowing researchers to see how the program impacts their well-being.

To be eligible for this program, participants need to be adults who are willing to commit to attending all three sessions and have a schedule that allows for their participation. They must also be part of the social security system and able to sign a consent form. At the end of the program, participants will share their thoughts through a satisfaction questionnaire and an interview, which will help the researchers understand how effective the program was. This trial is currently recruiting participants, and everyone is welcome, regardless of gender.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participant of legal age
  • Willingness to participate in the program - voluntary registration
  • Commitment to attend all 3 program sessions
  • Schedule compatible with participation in the 3 program sessions
  • Participant has understood, signed and dated the consent form
  • Participant affiliated to the social security system
  • Exclusion Criteria:
  • No desire to participate in the program - non-registration
  • Previous participation in MAEva program
  • No commitment to participate in the 3 program sessions
  • Agenda incompatible with the 3 program sessions

About Institut De Cancérologie De Lorraine

The Institut de Cancérologie de Lorraine (ICL) is a leading cancer research and treatment center in France, dedicated to advancing oncology through innovative clinical trials and comprehensive patient care. With a focus on multidisciplinary collaboration, ICL integrates cutting-edge research with clinical practice to enhance therapeutic outcomes and improve the quality of life for cancer patients. The institute is committed to fostering scientific discovery and translating findings into effective treatments, while adhering to the highest ethical standards in clinical research. Through its robust portfolio of clinical trials, ICL aims to contribute significantly to the understanding and management of various cancer types.

Locations

Vandœuvre Lès Nancy, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported